Progress in survival following three decades of allogeneic hematopoietic cell transplantation for myelodysplastic syndrome: A real‐world registry study in Japan-Reference-Cited by-同舟云学术

Progress in survival following three decades of allogeneic hematopoietic cell transplantation for myelodysplastic syndrome: A real‐world registry study in Japan

Published:2023-01-24 Issue:4 Volume:98 Page:
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:American J Hematol

Author:

Konuma Takaaki¹^ORCID,Itonaga Hidehiro²^ORCID,Ishiyama Ken³,Hamamura Atsushi⁴,Uchida Naoyuki⁵^ORCID,Ozawa Yukiyasu⁶,Katayama Yuta⁷,Sakurai Masatoshi⁸^ORCID,Ueda Yasunori⁹,Matsuoka Ken‐ichi¹⁰,Kawakita Toshiro¹¹,Eto Tetsuya¹²,Ara Takahide¹³,Kanda Junya¹⁴^ORCID,Onizuka Makoto¹⁵,Fukuda Takahiro¹⁶,Atsuta Yoshiko¹⁷¹⁸

Affiliation:

1. Department of Hematology/Oncology, The Institute of Medical Science The University of Tokyo Tokyo Japan

2. Department of Hematology Nagasaki University Hospital Nagasaki Japan

3. Department of Hematology Kanazawa University Kanazawa Japan

4. Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital Tokyo Japan

5. Department of Hematology Toranomon Hospital Tokyo Japan

6. Department of Hematology Japanese Red Cross Nagoya First Hospital Nagoya Japan

7. Department of Hematology Hiroshima Red Cross Hospital & Atomic‐Bomb Survivors Hospital Hiroshima Japan

8. Division of Hematology, Department of Medicine Keio University School of Medicine Tokyo Japan

9. Department of Hematology/Oncology and Transfusion and Hemapheresis Center Kurashiki Central Hospital Kurashiki Japan

10. Department of Hematology and Oncology Okayama University Hospital Okayama Japan

11. Department of Hematology National Hospital Organisation Kumamoto Medical Center Kumamoto Japan

12. Department of Hematology Hamanomachi Hospital Fukuoka Japan

13. Department of Hematology Hokkaido University Hospital Sapporo Japan

14. Department of Hematology and Oncology, Graduate School of Medicine Kyoto University Kyoto Japan

15. Department of Hematology and Oncology Tokai University School of Medicine Isehara Japan

16. Hematopoietic Stem Cell Transplantation Division National Cancer Hospital Tokyo Japan

17. Japanese Data Center for Hematopoietic Cell Transplantation Nagoya Japan

18. Department of Registry Science for Transplant and Cellular Therapy Aichi Medical University School of Medicine Nagakute Japan

Funder

Japan Agency for Medical Research and Development

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ajh.26839

Reference16 articles.

1. Effects of Acute and Chronic Graft-versus-myelodysplastic Syndrome on Long-term Outcomes Following Allogeneic Hematopoietic Cell Transplantation

2. Reduced Mortality after Allogeneic Hematopoietic-Cell Transplantation

3. Improvement of early mortality in single‐unit cord blood transplantation for Japanese adults from 1998 to 2017

4. Improved trends in survival and engraftment after single cord blood transplantation for adult acute myeloid leukemia

5. Induction chemotherapy followed by allogeneic HCT versus upfront allogeneic HCT for advanced myelodysplastic syndrome: A propensity score matched analysis

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic impact of the conditioning intensity on outcomes after allogeneic transplantation for MDS with low blasts: A nationwide retrospective study by the adult MDS working group of the Japan Society for Transplantation and Cellular Therapy;2023-12-21

2. Single‐unit unrelated cord blood transplantation versus HLA‐matched sibling transplantation in adults with advanced myelodysplastic syndrome: A registry‐based study from the adult MDS working group of the Japanese society for transplantation and cellular therapy;Hematological Oncology;2023-08-18

3. Should a matched sibling donor still be considered the primary option for allogeneic hematopoietic cell transplantation in patients over 50 years of age with myelodysplastic syndrome?;Bone Marrow Transplantation;2023-05-08

4. Allogeneic transplantation of bone marrow versus peripheral blood stem cells from HLA-identical relatives in patients with myelodysplastic syndromes and oligoblastic acute myeloid leukemia: a propensity score analysis of a nationwide database;Annals of Hematology;2023-03-15